Ajay Gupta1, Hediyeh Baradaran, Hooman Kamel, Ankur Pandya, Atul Mangla, Allison Dunning, Randolph S Marshall, Pina C Sanelli. 1. From the Departments of Radiology (A.G., H.B., P.C.S.) and Neurology (H.K., A.M.), Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York; Department of Public Health, Weill Cornell Medical College, New York, NY (A.P., A.D., P.C.S.); and Department of Neurology, Columbia University Medical Center, NewYork-Presbyterian Hospital, New York (R.S.M.).
Abstract
BACKGROUND AND PURPOSE: Increasing evidence suggests that carotid artery imaging can identify vulnerable plaque elements that increase stroke risk. We correlated recently proposed markers, soft and hard plaque thickness measurements on axial computed tomography angiography source images, with symptomatic disease status (ipsilateral stroke or transient ischemic attack) in high-grade carotid disease. METHODS: Soft plaque and hard plaque thickness were measured with a recently validated technique using computed tomography angiography source images in subjects with ≥70% extracranial carotid artery stenosis. Logistic regression analyses were used to assess the strength of association between soft and hard plaque thickness measurements and previous stroke or transient ischemic attack. Receiver operating characteristic analysis was also performed. RESULTS: Compared with asymptomatic subjects, those with symptomatic carotid disease had significantly larger soft plaque and total plaque thickness measurements and smaller hard plaque thickness measurements. Each 1-mm increase in soft plaque resulted in a 2.7 times greater odds of previous stroke or transient ischemic attack. Soft plaque thickness measurements provided excellent discrimination between symptomatic and asymptomatic disease, with receiver operating characteristic analysis showing an area under the curve of 0.90. A cutoff of 3.5-mm maximum soft plaque thickness provided a sensitivity of 81%, specificity of 83%, positive predictive value of 85%, and a negative predictive value of 78%. CONCLUSIONS: Increasing maximum soft plaque thickness measurements are strongly associated with symptomatic disease status in carotid artery stenosis. Prospective validation of these results may translate into a widely accessible stroke risk stratification tool in high-grade carotid artery atherosclerotic disease.
BACKGROUND AND PURPOSE: Increasing evidence suggests that carotid artery imaging can identify vulnerable plaque elements that increase stroke risk. We correlated recently proposed markers, soft and hard plaque thickness measurements on axial computed tomography angiography source images, with symptomatic disease status (ipsilateral stroke or transient ischemic attack) in high-grade carotid disease. METHODS: Soft plaque and hard plaque thickness were measured with a recently validated technique using computed tomography angiography source images in subjects with ≥70% extracranial carotid artery stenosis. Logistic regression analyses were used to assess the strength of association between soft and hard plaque thickness measurements and previous stroke or transient ischemic attack. Receiver operating characteristic analysis was also performed. RESULTS: Compared with asymptomatic subjects, those with symptomatic carotid disease had significantly larger soft plaque and total plaque thickness measurements and smaller hard plaque thickness measurements. Each 1-mm increase in soft plaque resulted in a 2.7 times greater odds of previous stroke or transient ischemic attack. Soft plaque thickness measurements provided excellent discrimination between symptomatic and asymptomatic disease, with receiver operating characteristic analysis showing an area under the curve of 0.90. A cutoff of 3.5-mm maximum soft plaque thickness provided a sensitivity of 81%, specificity of 83%, positive predictive value of 85%, and a negative predictive value of 78%. CONCLUSIONS: Increasing maximum soft plaque thickness measurements are strongly associated with symptomatic disease status in carotid artery stenosis. Prospective validation of these results may translate into a widely accessible stroke risk stratification tool in high-grade carotid artery atherosclerotic disease.
Authors: Jonathan M Coutinho; Sheldon Derkatch; Alphonse R J Potvin; George Tomlinson; Tim-Rasmus Kiehl; Frank L Silver; Daniel M Mandell Journal: Neurology Date: 2016-07-13 Impact factor: 9.910
Authors: P I Sajedi; J N Gonzalez; C A Cronin; T Kouo; A Steven; J Zhuo; O Thompson; R Castellani; S J Kittner; D Gandhi; P Raghavan Journal: AJNR Am J Neuroradiol Date: 2017-05-11 Impact factor: 3.825
Authors: Jonathan M Coutinho; Sheldon Derkatch; Alphonse R J Potvin; George Tomlinson; Leanne K Casaubon; Frank L Silver; Daniel M Mandell Journal: Neurology Date: 2016-11-18 Impact factor: 9.910
Authors: Karolin Johanna Paprottka; Damiana Saam; Johannes Rübenthaler; Andreas Schindler; Nora Navina Sommer; Philipp Marius Paprottka; Dirk André Clevert; Maximilian Reiser; Tobias Saam; Andreas Helck Journal: Radiol Med Date: 2017-02-24 Impact factor: 3.469
Authors: A Gupta; E E Mtui; H Baradaran; G Salama; A Pandya; H Kamel; A Giambrone; P C Sanelli Journal: AJNR Am J Neuroradiol Date: 2014-09-11 Impact factor: 3.825
Authors: Aditya M Sharma; Ajay Gupta; P Krishna Kumar; Jeny Rajan; Luca Saba; Ikeda Nobutaka; John R Laird; Andrew Nicolades; Jasjit S Suri Journal: Curr Atheroscler Rep Date: 2015-09 Impact factor: 5.113
Authors: H Baradaran; K Al-Dasuqi; A Knight-Greenfield; A Giambrone; D Delgado; E J Ebani; H Kamel; A Gupta Journal: AJNR Am J Neuroradiol Date: 2017-10-26 Impact factor: 3.825
Authors: Sumbal A Janjua; Pedro V Staziaki; Balint Szilveszter; Richard A P Takx; Thomas Mayrhofer; Orla Hennessy; Hamed A Emami; Jakob Park; Alexander Ivanov; Travis R Hallett; Michael T Lu; Javier M Romero; Steven K Grinspoon; Udo Hoffmann; Markella V Zanni; Tomas G Neilan Journal: Circ Cardiovasc Imaging Date: 2017-10 Impact factor: 7.792